What we do
Together, we work to educate the public about our industry and advocate for the policies and programs that will be needed to create a safe, fair and transparent pathway to market in the United States for our cell-based/cultured meat products. We aim to create an environment for our industry that will support continued innovation for years to come.
About cell-based/cultured meat, poultry and seafood
Our companies produce real meat, poultry and seafood directly from animal cells. In the next several years, through appropriate regulatory pathways, we expect our products will be in restaurants and on grocery store shelves around the United States.
AMPS Innovation member companies are committed to this work because we believe that cell-based/cultured meat, poultry and seafood will be a critical and sustainable component, in partnership with the overall agriculture sector, to meeting increased demand for animal protein as the world’s population continues to grow.
Current cell-based/cultured meat regulatory landscape
In March 2019, the United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) announced a formal agreement by which they plan to jointly regulate food products derived from the cells of livestock and poultry. Under the agreement, the FDA will oversee cell collection, cell banks, and cell growth and differentiation, while the USDA’s Food Safety and Inspection Service (FSIS) will oversee the production and labeling of these food products, just as FSIS regulates other meat and poultry. This joint framework would not apply to cell-based/cultured seafood, as seafood is regulated by FDA.
We are committed to working with USDA and FDA to provide additional clarity and for this framework to ensure the highest levels of safety and transparency are applied to our products.